Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis
Authors:
- 1 January 2018
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 476, 81-91
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adultsAnnals of Oncology, 2014
- Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphomaAnnals of Hematology, 2014
- Prognostic significance of serum albumin in patients with metastatic renal cell carcinomaMedical Oncology, 2014
- The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patientsThe American Journal of Surgery, 2013
- The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancerInternational Journal of Colorectal Disease, 2013
- Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancerClinics, 2013
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight LossNutrition and Cancer, 2001